# FDA Inspection 919999 - AxoGen Corporation - March 13, 2015

Source: https://www.keypedia.com/records/fda_inspections/axogen-corporation/5df42445-5b59-4ca8-8417-4e29551a6bc5
Source feed: FDA_Inspections

> FDA Inspection 919999 for AxoGen Corporation on March 13, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 919999
- Company Name: AxoGen Corporation
- Inspection Date: 2015-03-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1180500 - 2022-09-22](https://www.keypedia.com/records/fda_inspections/axogen-corporation/7b237e01-10e0-424f-a57a-fecbde8eb681)
- [FDA Inspection 1180500 - 2022-09-22](https://www.keypedia.com/records/fda_inspections/axogen-corporation/cede2fa2-264c-4d1b-b5f3-7d431a51c864)
- [FDA Inspection 1180500 - 2022-09-22](https://www.keypedia.com/records/fda_inspections/axogen-corporation/c037915e-768a-49e0-bef9-3bec643a09b2)
- [FDA Inspection 990232 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/axogen-corporation/7ee245c4-8add-45ea-9066-06f9df58e01c)
- [FDA Inspection 823344 - 2013-03-14](https://www.keypedia.com/records/fda_inspections/axogen-corporation/ab7608da-3292-4948-8569-d0ca3820805b)

Company: https://www.keypedia.com/companies/axogen-corporation/66fee473-9012-4a34-be96-52430f5ca334

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d